Physician profile
Robert C Youngman
NPI 1609827567
$1,535.33
in general payments reported to CMS, 2019-2025
20 companies · none reported in 2025
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $308 · 2020: $340 · 2021: $386 · 2022: $269 · 2023: $233.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $233.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $233.13 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Astellas Pharma US INC | $366.98 | 2019-2022 | |
| Pfizer INC. | $210.07 | 2019-2023 | |
| Janssen Biotech, INC. | $205.81 | 2019-2023 | Erleada |
| Axonics, INC. | $158.83 | 2020 | |
| Tolmar Pharmaceuticals, INC. | $90.71 | 2022 | |
| Boston Scientific Corporation | $70.25 | 2023 | Watchman Access System, Lithovue |
| Novartis Pharmaceuticals Corporation | $68.20 | 2022-2023 | |
| Genzyme Corporation | $57.50 | 2021-2022 | |
| Accord Healthcare, INC. | $47.57 | 2022-2023 | |
| Bayer Healthcare Pharmaceuticals INC. | $44.95 | 2021-2023 | |
| Urogen Pharma, INC. | $25.18 | 2022 | |
| Coloplast Corp | $23.90 | 2022 | |
| Allergan, INC. | $23.31 | 2020 | |
| Dentsply Ih INC. | $22.58 | 2021 | |
| Antares Pharma, INC. | $22.58 | 2022 |
Show all 20 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Blue Earth Diagnostics | $21.66 | 2021 | |
| Endo Pharmaceuticals INC. | $20.77 | 2019 | |
| Astrazeneca Pharmaceuticals Lp | $20.48 | 2020 | |
| Acerus Pharmaceuticals Corporation | $17.20 | 2020 | |
| Merck Sharp & Dohme LLC | $16.80 | 2022 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Robert Youngman listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.